The Business Times
business-time-50

Abbott

Travel & Wellness
HEALTH

A short-term monitoring method that’s driving habit change for Singapore’s diabetics

Abbott expects full-year adjusted earnings of US$5.38 to US$5.58 a share, against its previous forecast of US$5.55 to US$5.80.
Companies & Markets

Abbott cuts profit forecast in wake of cancer-screening deal

The company now expects annual adjusted profit between US$5.12 and US$5.18 per share, compared to its previous range of US$5.10 to US$5.20.
Companies & Markets

Abbott posts higher quarterly revenue on strong medical device demand

It's the first victory for the companies as they face more than 1,000 similar cases and both have previously lost trials, including one that ended with an almost US$500 million verdict against Abbott in July.
Consumer & Healthcare

Abbott, Reckitt unit defeat claims in baby formula trial

Illinois resident Margo Gill, who brought the case against Abbott, alleged that the company failed to warn that its formula could cause a potentially deadly disease called necrotizing enterocolitis (NEC) in premature babies.
Consumer & Healthcare

Abbott must pay US$495 million in premature infant formula trial, jury finds

Sales of Abbott's medical devices rose 10.2 per cent to US$4.66 billion, beating the average estimate.
Consumer & Healthcare

Abbott raises annual profit forecast as strong medical device sales power quarterly beat

The devices, one for the health-conscious and another for those with diabetes, follow Abbott’s FreeStyle Libre, which generates over US$1 billion every quarter and is sold under prescription for patients with diabetes.
Consumer & Healthcare

Abbott secures FDA clearance for two over-the-counter glucose monitors

Profit rose to 2.87 billion rupees (S$46.5 million) for the three months ended March 31, from 2.31 billion rupees a year earlier.
Companies & Markets

Drugmaker Abbott India posts Q4 profit rise on higher sales

Sales of Abbott’s medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries that were delayed during the Covid-19 pandemic.
Consumer & Healthcare

Abbott beats quarterly profit estimates on strong medical device sales

Abbott says the protein shake is first among the range of products lined up to be launched under its new brand, called Protality.
Consumer & Healthcare

Abbott launches protein shake brand to help people on weight-loss drug

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More